PerkinElmer appoints CFO and chairmain of the board of directors
New Chief Financial Officer: Frank A. “Andy” Wilson
WALTHAM, Mass. PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced the appointment of Frank A. “Andy” Wilson as senior vice president, chief financial officer, and chief accounting officer for the Company. In this role, Wilson will have overall leadership responsibility for the strategy and operations for all of the Company’s finance and control functions. He will assume his new role on May 18.
“Andy brings to PerkinElmer over 20 years of expertise in developing effective financial and business strategies for driving financial performance,” commented Robert Friel, the Company’s chairman and CEO. “His experience in the medical and environmental industries combined with his strong strategic skills and general management experience will be a significant asset to PerkinElmer.”
Prior to joining PerkinElmer, Wilson was the corporate vice president of investor relations at Danaher Corporation, a leading manufacturer of professional instrumentation, medical and industrial technologies and tools and components. While at Danaher, he held key financial and business management roles. Wilson joined Danaher in 1997, after several years with AlliedSignal, Inc. (now Honeywell International, Inc.) where he served as chief financial officer for one of its businesses. His prior experience includes five years with PepsiCo Inc. in financial leadership and controllership positions and five years with KPMG Peat Marwick.
Wilson received his Bachelors Degree in accounting from Baylor University and is a certified public accountant.
PerkinElmer Appoints Robert F. Friel As Chairman of the Board of Directors
PerkinElmer, Inc. has also announced that its board of directors has appointed the Company’s president and chief executive officer, Robert F. Friel, to the additional role of chairman of the board of directors. The announcement comes in conjunction with the Company’s annual shareholders meeting held on April 28, 2009. The appointment of Mr. Friel to chairman is part of PerkinElmer’s 2007 leadership succession plan designed to support the Company’s growth strategy and provide strong leadership continuity. Friel succeeds Gregory L. Summe, chairman since 1999, who did not stand for reelection.
“Rob’s leadership and deep understanding of PerkinElmer’s businesses, organization and entrepreneurial culture makes him ideally suited to lead the Company going forward,” said Summe. “I believe that PerkinElmer today has an executive management team in place that is well positioned to continue driving the global growth and profitability of the Company through providing greater value to customers worldwide.”
“Greg’s vision, commitment and strong leadership over the last decade have been instrumental in transforming PerkinElmer from a diversified company with an offering largely focused in government services, to a $2 billion global technology and health sciences leader,” said Friel. “We will leverage our strong operating foundation to continue expanding our human and environmental health businesses and broadening our footprint in emerging markets. We thank Greg for all of his contributions to the Company.”
Friel joined PerkinElmer in 1999 as chief financial officer and was appointed vice chairman and president of the Company’s Life and Analytical Sciences business in 2006. In 2007, Friel was appointed president and chief operating officer of the Company. He succeeded Mr. Summe as chief executive officer in 2008.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index.
PerkinElmer Inc. 1-877-PKI-NYSE